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Introduction: An innovative approach, called associated liver partition and portal vein ligation for staged
hepatectomy(ALPPS), has made possible a marked increase in future liver remnant (FLR) volume over a short period
of time, thus permitting extended hepatectomy.
Case description: This report describes ALPPS in a 63-year-old male patient with rectal cancer and synchronous multiple
liver metastases. The primary lesion was resected, followed by chemotherapy. We had planned to completely resect the
metastases in both liver lobes, but CT volumetry revealed a very small FLR (364 ml, 29% of the total liver volume, 0.61% of
total body weight). His indocyanine green retention rate at 15 minutes was 12.7%. Because of the risk of tumor
progression in the interim, we performed ALPPS. During the first stage, the tumor in segment 3 was resected, the
right lobe was mobilized, the liver was partitioned, and the right portal vein was ligated. The right hepatic artery,
duct and vein were secured with vessel loops. CT on postoperative day 6 showed sufficient FLR increase (from 364
ml to 573 ml, or from 0.61% to 0.96% of total body weight) and ICGR15 improvement to 3.4%. The second stage of
ALPPS was on postoperative day 7, completing resection of the metastases. The patient recovered well and was
discharged 21 days after the second step.
Discussion and evaluation: The ALPPS approach has many advantages, but it lacks evidence of long-term results.
Considering the high mortality and morbidity rates of ALPPS, it is essential to evaluate its risks and benefits in individual
patients and determine the strict criteria for this surgical method.
Conclusions: ALPPS procedure rapidly increases FLR, permitting extended hepatectomy for patients with initially
insufficient FLR.
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Hepatectomy for colorectal liver metastases has proven
effective and the only method that can result in radical
cure (Rodgers & McCall 2000; Martin & Warren 2000;
Penna & Nordlinger 2002). Future liver remnant (FLR)
volume and liver function are important in preventing
postoperative liver failure and determining the indication
of surgery. In patients with metastatic liver tumors, the* Correspondence: yo14408@kchnet.or.jp
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in any medium, provided the original work is pmorbidity of viral hepatitis is lower than that of hepato-
cellular carcinoma. Many of these patients receive
chemotherapy before hepatectomy, which may result
in chemotherapy-induced liver damage. It is essential
to maintain sufficient FLR volume in patients undergoing
hepatectomy for liver metastases.
Patients with FLR volume inadequate for liver resection
frequently undergo preoperative portal vein embolization
(PVE) or two-stage hepatectomy often combined with
PVE or portal vein ligation (PVL) (Azoulay et al. 2000;
Adam et al. 2000; Jaeck et al. 2003; Jaeck et al. 2004). PVE,Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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and tumors on the non-embolic side may rapidly progress.
Because completion of resection requires a comparatively
long period of time in both methods, residual tumors may
be enlarged.
Associated liver partition and portal vein ligation
(ALPPS) for staged hepatectomy was recently reported
to be useful in patients with liver metastases and low FLR
volume (Baumgart et al. 2011; de Santibañes & Clavien
2012; de Santibañes et al. 2012; Schnitzbauer et al. 2012;
Li et al. 2013). This method has been found to markedly
increase FLR volume over a short period of time and may
overcome the problems of PVE or usual two-staged
hepatectomy.
We describe a patient who underwent the ALPPS pro-
cedure for multiple liver metastases of rectal cancer and
achieved R0 resection.Case report
A 63-year-old man presenting with a positive fecal occult
blood test was diagnosed with middle rectal cancer by col-
onoscopy. He had a history of cerebral infarction and was
taking an antiplatelet agent. Laboratory tests, including
those for tumor markers, were approximately normal, and
he was negative for markers of viral hepatitis. CT revealed
synchronous multiple liver metastases, mainly in the right
lobe (Figure 1). The patient was pathologically diagnosed
with moderately differentiated tubular adenocarcinoma,
classified as T3N1 in the TNM system. Because this pa-
tient had at least eight metastases in the liver, we decidedFigure 1 CT scan of this patient, showing multiple liver metastases in theto resect the primary lesion, by high anterior rectal resec-
tion in open sugery, followed by chemotherapy.
Following resection of the primary tumor, the patient
was started on postoperative chemotherapy with XELOX
plus bevacizumab. CT showed a partial response after
seven cycles of chemotherapy. However, the patient ex-
perienced side effects, including nausea, general fatigue,
peripheral neuropathy, and anemia. He wanted to stop
the chemotherapy and undergo liver resection. MRI re-
vealed seven metastases in the right lobe, one in segments
4 and 5, and one in segment 3. R0 resection therefore re-
quired right hepatectomy and partial resection of segment
3 (Figure 2). His liver function tests were almost normal,
but his indocyanine green retention rate at 15 minutes
(ICGR15) was 12.7%, which was thought to be slightly
deteriorated because of the chemotherapy. CT volume-
try revealed a very small left lobe of the liver. The pro-
jected FLR volume was 364 ml, 29% of total liver volume
and 0.61% of the total body weight that was 59.6 kg. The
FLR volume would therefore be insufficient following re-
section. PVE was considered but might not always have
induced sufficient remnant liver hypertrophy. Moreover,
the time required to wait after PVE, about 4 weeks, may
have increased the risk of tumor progression, especially on
the non-embolic side. Conventional two-stage hepatectomy
with PVE or PVL was also considered, but the appoach re-
quires at least 4 weeks for complete resection after FLR
hypertrophy, which develops adhesions. Furthermore, the
first stage operation may further stimulate tumor growth
due to the increase of release of growth factors. We there-
fore decided to adopt the ALPPS approach.liver.
Figure 2 Diffusion weighted MRI of this patient, showing liver metastases in the right lobe and in segment 3.
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cision, and ultrasonography confirmed that there were
no other lesions. After mobilization of the right lobe, the
gall bladder was resected and the right hepatic artery,
right portal vein, and right hepatic vein secured with
vessel loops. The tumor in segment 3 was enucleated,
and the liver parenchyma was partitioned almost along
the Rex-Cantlie line so that all other tumors were on the
resected side. Total inflow occlusion using the Pringle
maneuver was performed during parenchymal transec-
tion. The right hepatic duct was separated and secured
with a vessel loop, followed by ligation of the right portal
vein. The resulting partitioned right lobe retained artery
inflow, biliary outflow, and hepatic outflow, but had no
portal vein inflow (Figure 3). We did not use an exclu-
sion bag for the right lobe specimen. A Blake drain® was
inserted into the cut surface of the liver through the
right subphrenic space. Seprafilm®, a bioresorbable mem-
brane that prevents adhesion, was placed around the de-
tached liver surface and under the abdominal incision.
The operation required 216 minutes, and estimated
blood loss was 798 ml. The total duration of the Pringle
maneuver was 35 minutes.
The patient was able to ingest foods on the next day.
He experienced only mild fatigue, but gradually recov-
ered. Liver function tests peaked one day after surgery,
with total bilirubin concentration at 1.8 mg/dl, AST at
1415 IU/l, ALT at 871 IU/l, LDH at 1091 IU/l and PT-
INR at 1.17, with all showing gradual improvement. A
CT scan on postoperative day 6 showed sufficient FLRenlargement, from 364 ml to 573 ml, or from 0.61% to
0.96% of total body weight (Figure 4). Growth rate was
34.8 ml/day. The partitioned right lobe atrophy was not
seen, increasing from 889 ml to 908 ml. The right portal
vein was occluded in the root, but intrahepatic portal
vein flow was unexpectedly found in an arterial phase
because of arterioportal shunt formation in the right
Glissonian peddicle. ICGR15 was 3.4% on the same day.
The patient’s general condition and remnant liver
function were thought to be sufficient for completion of
resection. The second stage of ALPPS surgery was there-
fore performed on postoperative day 7.
During the second stage operation, we made only a
median incision. Although several adhesions were observed
around the cut surface of the partitioned liver, all could be
easily lysed. Both sides of the partitioned liver looked al-
most normal and viable. The vessels and the right hepatic
duct secured during the first stage of ALPPS had been
identified. The right portal vein and the right hepatic artery
were ligated and cut. Then the right hepatic duct was di-
vided with a stapler. The right hepatic vein was separated in
the sameway, followed by removal of the right hepatectomy
specimen (Figure 5). The second stage operation required
52 minutes, and estimated blood loss was 160 ml. The
patient required no blood transfusions during ALPPS.
Examination of the resected specimen showed mul-
tiple white solid nodules, of maximum size 27 × 25 mm.
Some of the nodules were viable, and others were almost
entirely necrotic because of preoperative chemotherapy.
Macroscopic examination indicated the presence of
ab
Figure 3 The first stage of ALPPS. (a,b) Shown are the right hepatic artery (yellow arrow), ligated right portal vein (white arrow), right hepatic
duct (blue arrow), right hepatic vein (red arrow) and middle hepatic vein (purple arrow).
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ules were microscopically diagnosed as liver metastases
from a known rectal adenocarcinoma (Figure 5b).
Histological examination showed zone 3 (centrilobular)
necrosis, a finding not observed in the adjacent (segment
3) specimen (Figure 5c). There was no evidence in this pa-
tient of sinusoidal dilatation caused by oxaliplatin-based
chemotherapies.
The patient’s general condition improved markedly.
Levels of transaminase and total bilirubin did not in-
crease after the operation. Other laboratory tests showed
nothing particularly abnormal (Figure 6). CT scans on
postoperative day 7 showed greater FLR enlargement
(from 573 ml to 643 ml), but the growth rate was slowerthan after the first stage operation (10 ml/day vs 34.8 ml/
day). ICGR15 was 18.3% on postoperative day 14. This pa-
tient recovered uneventfully and was discharged home on
postoperative day 21 after the second step. He now
recieves adjuvant chemotherapy. He is free of tumor
reccurence 5 months after ALPPS.
Discussion
When extended hepatectomy is required for R0 resection,
FLR volume may be sufficient or insufficient to prevent
postoperative liver failure. If FLR volume is insufficient,
PVE, PVL, or two-stage hepatectomy may be performed
for FLR hypertrophy. FLR volume was thought to increase
about 35% at 4 to 6 weeks after PVE (Hemming et al.
Figure 4 CT scan (a) before and (b) 6 days after the initial ALPPS, showing marked FLR enlargement. (c,d) arterial phase imaging. An
arterioportal shunt was formed in the right Glissonian pedicle (yellow arrow).
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and PVL found that 4.8% of subjects in the PVE group
and 7.4% of those in the PVL group failed liver hyper-
trophy, with 17.46% and 29.29%, respectively, showing
interval disease progression. The resectability rate follow-
ing PVE/PVL was estimated to be 78%. Moreover, patientsFigure 5 Histological findings of the right hepatectomy specimen. (a,b) m
adenocarcinoma, (d) zone 3 (centrilobular) necrosis.with metastases on both lobes of the liver are at particu-
larly great risk for a rapid increase of tumors in FLR after
PVE/PVL (Hemming et al. 2003; Elias et al. 1999).
In conventional two-stage hepatectomy, minor resection
of tumors on the FLR side often combined with first-stage
PVE/PVL, followed by major extended lobectomy afterultiple liver metastases (arrow) and cut surface (triangle). (c) tubular
Figure 6 Perioperative laboratory tests. (a) AST, ALT and LDH. (b) T-Bil, D-Bil, APTT and PT. (c) CRP, WBC and PLT. (d) Alb, ChE and TCH.
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Jaeck et al. 2004; Tanaka et al. 2007; Kianmanesh et al.
2008). This method was found to result in 30-40% FLR
hypertrophy. However, these patients were also at risk of
rapid tumor progression because the interval to radical re-
section is comparatively long. Resectability rates have been
reported to range from 70-90%. PVE/PVL and hepatec-
tomy may increase growth factors and cytokines, which
may induce rapid tumor growth (Hemming et al. 2003;
Elias et al. 1999; Kokudo et al. 2001; Jiang et al. 1999),
Thus, the interval required for complete resection should
be minimized.
The ALPPS procedure, first reported in 2011 (Baumgart
et al. 2011), is an innovative staged hepatectomy that com-
bines PVL and liver partition during the first stage of re-
section. Portal vein occlusion, interruption of intrahepatic
vascular flow to the associated liver, and inflammation at
the hepatectomy site have been found to promote FLR re-
generation, as well as inducing rapid, marked hypertrophy.
Using this method, FLR was reported to increase 70-90%
in about a week (Schnitzbauer et al. 2012; Li et al. 2013;
Alvarez et al. 2013; Torres et al. 2013; Schadde et al. 2014).
The partitioned liver, which is fed predominantly by
the hepatic artery because of portal vein occlusion after
the first stage operation, has been reported to complement
liver functions until FLR enlargement (de Santibañes &
Clavien 2012; de Santibañes et al. 2012). In this patient, an
arterioportal shunt was formed in the Glissonean pedicle,
recanalizing portal flow and suggesting that the partitionedliver had sufficient liver function. Thus, even if the second
surgery had been postponed or canceled because of insuffi-
cient FLR hypertrophy, serious problems, such as liver in-
sufficiency, necrosis, abscess, or biliary leak, would not
have occurred.
We found that ICGR15 in this patient was markedly
improved 6 days after the first stage operation. This was
not only due to recovery from chemotherapy-induced
liver damage, but to enlarged FLR and the activity of the
remaining liver.
The rapid and marked hypertrophy resulting from
ALPPS has many advantages. First, we usually perform
minor hepatectomy, or clean-up resection on the non-
PVE side, during the first stage. Second, the high rate of
FLR increase makes possible extended liver resection in
patients without sufficient FLR hypertrophy via the con-
ventional approach. Third, the removal of residual tu-
mors after a short interval can reduce the risk of disease
progression, making the complete resection rate com-
paratively high, preventing the development of adhesions
and facilitating the second step.
However, ALPPS has several drawbacks, including
high operative mortality and morbidity rates. Severe
complications, including liver failure, sepsis, and bile
leakage, have been reported. Additionally, it is not clear
whether increased liver capacity leads to functional im-
provement (Dokmak & Belghiti 2012). In performing
right trisegmentectomy in ALPPS, both the arterial and
portal vein flow to segment 4 are shut off after the first
Ome et al. SpringerPlus  (2015) 4:194 Page 7 of 7step, increasing the risk that segment 4 will become nec-
rotic. However, as in this patient, ALPPS without the need
to remove segment 4 (e.g. right hepatectomy) is compara-
tively safe. Our first experience with ALPPS showed an ex-
cellent short-term result.
The ALPPS approach is still a new surgical method,
lacking evidence of long-term results. Complications,
high risk groups and optimal candidates for surgery have
not yet been identified. The high mortality and morbidity
rates of ALPPS make it essential to evaluate its risks and
benefits in individual patients and determine the strict cri-
teria for this surgical method.
Conclusion
Complete resection of liver metastases of colorectal
carcinoma is the only potentially curative method. The
ALPPS procedure induces FLR enlargement rapidly,
permits extended hepatectomy and offers a chance of
curative resection for patients with liver metastases.
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